Lamdong Pharmaceutical Joint Stock Company reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was VND 49,612.48 million compared to VND 40,428.91 million a year ago. Net income was VND 1,620.92 million compared to net loss of VND 4,986.82 million a year ago. Basic earnings per share from continuing operations was VND 128 compared to basic loss per share from continuing operations of VND 393 a year ago. Diluted earnings per share from continuing operations was VND 128 compared to diluted loss per share from continuing operations of VND 393 a year ago.